Tetraphase Pharmaceuticals Inc (TTPH.OQ)
19 Jan 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|74||2011||Chairman of the Board of Directors|
|56||2008||President and Chief Executive Officer, Director|
|51||2017||Principal Financial Officer, Principal Accounting Officer, Senior Vice President - Finance|
|2017||Chief Financial Officer|
|44||2015||Senior Vice President, General Counsel|
- BRIEF-Tetraphase Pharmaceuticals Announces Submission Of NDA To FDA For Eravacycline To Treat Intra-Abdominal Infections
- BRIEF-Millennium Management Llc Reports 5.3 Pct Passive Stake In Tetraphase Pharmaceuticals As On Dec 14
- BRIEF-Tetraphase Pharmaceuticals Q3 loss per share $0.63
- BRIEF-Tetraphase Pharmaceuticals signs commercial supply agreement with Finorga
- BRIEF-TETRAPHASE PHARMACEUTICALS APPOINTS KAM UNNINAYAR AS CFO